| Trial ID: | L1196 |
| Source ID: | NCT00004495
|
| Associated Drug: |
Cyanocobalamin
|
| Title: |
Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients With End Stage Renal Disease Receiving Hemodialysis
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End Stage Renal Disease|Hyperhomocysteinemia
|
| Interventions: |
DRUG: cyanocobalamin|DRUG: folic acid|DRUG: pyridoxine
|
| Outcome Measures: |
|
| Sponsor/Collaborators: |
Sponsor: Georgetown University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
84
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT
|
| Start Date: |
1999-06
|
| Completion Date: |
2000-09
|
| Results First Posted: |
|
| Last Update Posted: |
2015-03-25
|
| Locations: |
Georgetown University Medical Center, Washington, District of Columbia, 20007, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00004495
|
